Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001414

Pres. Research & Development bought 2,067 shares at $2.22 ($4,589)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-06-15 Purchase +2,067 $2.22 $4,589 19,198 D
Open-market purchases · 2,067 sh · avg $2.22 · $4,589
Loading xslF345X06/form4.xml…